Agenda

Section V:Foods for Special Medical Purposes (FSMPs) Session 1:Current Situation of Market Access and Clinical Use of FSMP in China and Abroad

Feb 18,2025

Session 1:Current Situation of Market Access and Clinical Use of FSMP in China and Abroad

Moderator:Lawrence LI Chief Science Officer,Sainte Nutrition Food Co.LTD
Supported by:Nestlé、Abbott、SFG、Sainte Nutrition Food Co.LTD

2025-02-18 14:00-14:10

Introductory Presentation:Addressing the ‘Last Mile’ Challenge for High-Quality Development of FSMP Industry

Gu Xinxin Ms, President of Nestlé Health Sciences Greater China and Head of Global Strategy and Marketing
2025-02-18 14:10-14:30

Innovation and Clinical Benefits of Non-Complete Medical Nutrition Products—A Case Study of “Abound”

Li,Fei Associate Director, Abbott Nutrition (China) R&D center
2025-02-18 14:30-14:50

Improvement of clinical outcomes and cost-effectiveness ratio (C/Eratio) based on nutritional risk screening (NRS-2002) and special medical food (FSMP)

Yu Kang professor, Director of Clinical Nutrition Department,Peking Union Medical College Hospital
2025-02-18 14:50-15:10

The current situation of foreign specialty medicine admission and Nestle health science product admission

Kailash Tayde Global Regulatory Operations Lead, Nestle Health Science
2025-02-18 15:10-15:30
2025-02-18 15:30-15:50

Reflections on Real-World Research of FSMP in China under the New Policy Background

Li Yahui Professor, Jiangnan University